Page last updated: 2024-10-30

metformin and Embryopathies

metformin has been researched along with Embryopathies in 3 studies

Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Albaghdadi, AJ1
Hewitt, MA1
Putos, SM1
Wells, M1
Ozolinš, TR1
Kan, FW1
Fraser, R1
Shahine, L1
Lathi, RB1
Dahan, MH1

Reviews

1 review available for metformin and Embryopathies

ArticleYear
Gestational diabetes mellitus: developments in diagnosis and treatment.
    Women's health (London, England), 2009, Volume: 5, Issue:3

    Topics: Amniotic Fluid; Diabetes, Gestational; Female; Fetal Diseases; Humans; Hyperinsulinism; Hypoglycemic

2009

Other Studies

2 other studies available for metformin and Embryopathies

ArticleYear
Tacrolimus in the prevention of adverse pregnancy outcomes and diabetes-associated embryopathies in obese and diabetic mice.
    Journal of translational medicine, 2017, 02-13, Volume: 15, Issue:1

    Topics: Animals; Bone and Bones; Diabetes Mellitus, Experimental; Diet, High-Fat; Female; Fetal Diseases; Gl

2017
Metformin and fetal malformations.
    Fertility and sterility, 2007, Volume: 87, Issue:5

    Topics: Female; Fetal Diseases; Fetus; Humans; Metformin; Pregnancy

2007